Substance Use Disorders Treatment Options
Impact on your practice
This is informational content about treatment options for substance use disorders. While useful for clinical knowledge, it has no direct impact on therapist billing, licensing, or practice requirements.
Key facts
Educational content on SUD treatment modalities and options
Part of SAMHSA's SUD Treatment Month awareness initiative
No policy or reimbursement changes
Therapy Companion analysis
This SAMHSA awareness initiative has minimal direct operational impact on your practice, but it signals important market and referral trends you should monitor. The document emphasizes that 48.5 million Americans (17% of the population) had a SUD in the past year, and that treatment combinations of behavioral therapy, medications, and recovery supports are evidence-based. If you're an LCSW, LPC, MFT, or psychologist, this means the demand for your services as part of integrated SUD treatment teams is substantial and growing. However, the document does not announce new reimbursement rates, prior authorization requirements, or billing code changes. Your income from SUD-related services will continue to depend on your existing insurance contracts and state Medicaid rates—this awareness campaign does not alter those. The emphasis on "combinations of behavioral therapies, medications, and recovery supports" suggests payers will increasingly expect you to document your role within a coordinated care model. If you're not currently tracking which of your clients have diagnosed SUDs or documenting your clinical coordination with prescribers and recovery programs, you should begin doing so to justify medical necessity and demonstrate value to insurers. The mention of FDA-approved medications (buprenorphine, methadone, naltrexone for opioids; acamprosate, disulfiram, naltrexone for alcohol) underscores that your therapeutic work is most billable when paired with pharmacotherapy—standalone counseling for SUD may face increasing scrutiny from payers seeking outcomes data.
Background
SAMHSA launched "SUD Treatment Month" in January 2025 as part of a broader federal effort to normalize and expand access to substance use disorder treatment. This reflects the ongoing opioid crisis and the Biden administration's focus on behavioral health integration. The document's emphasis on the DSM-5 diagnostic criteria and the distinction between SUD and addiction is meant to reduce stigma and encourage earlier intervention. Clinically, this is sound; operationally, it signals that federal agencies are pushing the narrative that SUD is a treatable medical condition requiring multidisciplinary care. For therapists, this creates both opportunity and pressure: opportunity because referrals and demand for your services should increase as awareness grows, but pressure because payers will expect you to demonstrate that your therapy is part of an evidence-based treatment plan that includes medication management and measurable outcomes.
What you should do
Audit your current SUD client population and documentation: identify which clients have a diagnosed SUD (using DSM-5 criteria), which are on FDA-approved medications, and whether you are documenting your clinical coordination with their prescriber. This data will help you justify medical necessity to insurers and prepare for payer audits.
Review your intake and assessment forms to ensure you are systematically screening for substance use using validated tools (SAMHSA's Screen4Success is mentioned as an example). If you are not screening, begin doing so to identify clients who may benefit from integrated treatment and to position your practice as part of the SUD treatment ecosystem.
Establish or strengthen referral relationships with prescribers, medication-assisted treatment (MAT) programs, and recovery support services in your area. Document these referrals in your clinical notes. Payers increasingly expect evidence of care coordination, and this documentation will support your billing and demonstrate value.
If you bill Medicaid, verify that your state's Medicaid program covers behavioral health services for SUD and confirm your reimbursement rate. Some states have enhanced rates for SUD treatment; others do not. This awareness campaign may prompt state legislatures to revisit SUD coverage, so monitor your state's Medicaid updates.
Prepare to articulate your specific role in SUD treatment (e.g., trauma-informed therapy, relapse prevention, family counseling) in your marketing and insurance credentialing materials. As demand grows, payers will want to understand what you offer and how it complements medication and peer support.
Notable excerpts
"Research shows that many people with SUDs respond well to combinations of behavioral therapies, medications, and recovery supports." (SAMHSA, January 2025) — This underscores that your therapy is most defensible to payers when documented as part of a coordinated, multimodal treatment plan.
"In 2023, 48.5 million people 12 or older, or 17 percent of the U.S. population, had a SUD within the past year." (SAMHSA, citing 2023 NSDUH) — This prevalence data supports the business case for expanding SUD services in your practice and justifies investment in staff training and referral partnerships.
"SUDs are often long-term health conditions that can carry risk of recurrence even after years of recovery." (SAMHSA, January 2025) — This language legitimizes ongoing therapeutic contact and supports billing for maintenance/relapse prevention services, not just acute treatment.
View full source text
Policy changes drive denial patterns
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.
Related policy changes
[MA] H4895: Expanding access to mental health services
This bill aims to expand mental health service access in Massachusetts and has cleared committee with a favorable recommendation. Depending on final language, it could affect reimbursement rates, telehealth authorization, or insurance coverage requirements.
[TN] SB1248: AN ACT to amend Tennessee Code Annotated, Title 4; Title 8; Title 33; Title 39; Title 49; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to mental health.
This comprehensive TN mental health bill touches multiple code sections and could affect licensure, scope of practice, insurance requirements, and workforce regulations. Therapists should monitor its progress closely as it moves through committee.
Advancing the Future of Behavioral Health Data Exchange
This policy direction addresses a critical pain point for therapists: the lack of integrated health data exchange with primary care and medical providers. Improved interoperability could reduce documentation burden, improve care coordination, and reduce liability from medication interactions or missed diagnoses. However, it may also increase compliance requirements and data security obligations.
Opinion: MAHA is rewriting the vocabulary of American mental health care
Federal deprescribing initiatives create new clinical and billing opportunities for therapists while potentially pressuring prescribing practices. Therapists should understand the evidence, reimbursement rules, and ethical considerations around medication tapering to protect clients and navigate changing clinical norms.